Compare LMAT & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | PARR |
|---|---|---|
| Founded | 1983 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2006 | N/A |
| Metric | LMAT | PARR |
|---|---|---|
| Price | $83.30 | $35.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $101.83 | $40.00 |
| AVG Volume (30 Days) | 177.1K | ★ 1.2M |
| Earning Date | 11-06-2025 | 02-24-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | ★ 27.40 | N/A |
| EPS | 2.32 | ★ 4.51 |
| Revenue | $240,866,000.00 | ★ $7,483,631,000.00 |
| Revenue This Year | $15.17 | N/A |
| Revenue Next Year | $9.07 | N/A |
| P/E Ratio | $35.31 | ★ $8.27 |
| Revenue Growth | ★ 13.07 | N/A |
| 52 Week Low | $71.42 | $11.86 |
| 52 Week High | $105.55 | $48.40 |
| Indicator | LMAT | PARR |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 38.26 |
| Support Level | $79.40 | $34.85 |
| Resistance Level | $86.00 | $38.64 |
| Average True Range (ATR) | 2.22 | 1.57 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 45.64 | 22.13 |
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.